Advanced SERSome-based artificial-intelligence technology for identifying medicinal and edible homologs.

Journal: Talanta
PMID:

Abstract

Medicinal and edible homologs (MEHs) offer significant preventive and therapeutic benefits for various diseases and health functions. However, the widespread application of MEHs faces significant challenges, particularly in quality control and rapid identification. In this study, we present a novel approach that combines surface-enhanced Raman spectroscopy (SERS) based on spectral set, referred as "SERSome", with deep learning to develop an identification model for analyzing MEHs. The platform uses silver nanoparticles prepared via reduction with NaBH, activation with sodium borohydride, and aggregation with calcium ions. The method avoids the use of additional protective agents during the reaction process, thereby reducing interference from the protective agents and other materials. Additionally, the method also overcomes the fluorescence interference from MEHs. SERSomes provide comprehensive molecular fingerprint recognition, significantly enhancing the system's detection accuracy. The introduction of Ca as aggregation agent promotes the aggregation of silver nanoparticle, significantly enhancing the electromagnetic field of the nanoparticle system. The study achieves up to 98 % accuracy in identifying specific MEHs. The integration of SERSomes with deep learning offers a promising methodology for the rapid and modern detection of MEHs, advancing the MEHs industry and contributing to the protection of human health.

Authors

  • Shuang Jiang
    Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Yue Zhao
    The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China.
  • Qingyu Meng
    Department of Health Statistics, Shanxi Medical University, Taiyuan, Shanxi, China.
  • Rongheng Ma
    The Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University, Heilongjiang 150081, PR China.
  • Xiaomeng Sun
    State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Heilongjiang, 150081, P. R. China.
  • Xiaoming Lyu
    State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Heilongjiang 150081, PR China.
  • Li Zhang
    Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.
  • Guangrun Wu
    State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Heilongjiang, 150081, P. R. China.
  • Xiaotong Wang
    Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine.
  • Yiyang He
    State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, China; Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Jiayue Liang
    State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, China; Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Yuxin Qiao
    Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Zhibin Wang
    School of Information and Communication Engineering, North University of China, Taiyuan 030051, China. wangzhibin@nuc.edu.cn.
  • Yanli Wu
    State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Heilongjiang 150081, PR China.
  • Jing Wu
    School of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, Jiangsu, China.
  • Chunjuan Yang
    College of Pharmacy, Harbin Medical University, Harbin, China.
  • Huimin Yu
    Chinese Medicine Department, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
  • Yang Li
    Occupation of Chinese Center for Disease Control and Prevention, Beijing, China.